K.C. Pharmaceuticals recalls over 3 million eye drop bottles sold at major retailers due to sterility concerns. The FDA classifies the recall as Class II, with no reported injuries so far.
Posts tagged as “FDA”
In 2024, the FDA announced a voluntary recall of over 170,000 bottles of Martinelli’s Apple Juice due to potential contamination with patulin, a mycotoxin that can pose health risks. The recall affects 10-ounce glass bottles produced in December 2023 and distributed across 28 states, with the FDA classifying it as Class II, indicating a low probability of serious health consequences. S. Martinelli & Company is cooperating with the recall, advising consumers to return affected products for a refund, while the FDA continues to monitor the situation.
The Trump administration has released documents to support its claim that Kilmar Abrego Garcia, recently deported to a mega-prison in El Salvador, was affiliated with the MS-13 gang, amid ongoing controversy. U.S. District Judge James Boasberg ruled against the administration, suggesting potential criminal contempt of court for violating a deportation block, thereby intensifying the constitutional debate between the executive branch and the judiciary. The case, described as an "administrative error" by a government lawyer, has highlighted the complexities of immigration enforcement and judicial oversight, drawing significant public attention.
A recent CDC report reveals a significant increase in autism spectrum disorder prevalence among U.S. children, with diagnoses rising from one in 54 in 2016 to one in 31 by 2022. The report highlights variations in autism rates across states, emphasizing the disorder's complexity and the necessity for further research. Despite Robert F. Kennedy Jr.'s pledge to identify autism's cause by September, experts express skepticism due to the intricate nature of autism research, underscoring the need for continued public health efforts and support for affected families.
The FDA has begun screening imports of cinnamon from multiple countries for toxic lead contamination, after reports of children becoming ill from eating pouches of applesauce and apple puree. The agency is working with the CDC to monitor the health of those affected and is urging consumers to check their pantries for recalled products and to contact their healthcare provider if they have any concerns. The FDA is also continuing to investigate the source of the contamination and is working to prevent similar incidents in the future.
The FDA is expanding an investigation into potentially lead-tainted pouches of apple cinnamon fruit puree marketed for children, with reports of seven illnesses in at least five states possibly linked to the contaminated puree. Two new companies have recalled certain cinnamon applesauce products due to the potential for high levels of lead, and the FDA is urging parents to check their homes for the recalled products and to discard them immediately. The FDA is working with the CDC to monitor the situation and is recommending that children under the age of six be tested for lead poisoning if they have been exposed to lead-tainted products.
The FDA is considering the approval of exa-cel, a new drug developed by Vertex Pharmaceuticals that could be the first cure available for many patients with sickle cell disease. The illness affects an estimated 100,000 people in the U.S., mostly Black, and causes anemia, pain, and organ damage. If approved, exa-cel would be the first drug to use the groundbreaking gene-editing tool CRISPR and provide a universally available, potentially curative option for individuals with sickle cell. The FDA is expected to make a decision on the drug in the coming months.
The FDA has issued a warning about the potential dangers of probiotics for preterm infants, citing more than two dozen adverse events linked to the products since 2018. The agency is investigating whether probiotics have contributed to other cases in babies and has sent a letter to health care providers about the dangers of these products. Parents and caregivers are urged to talk to their health care provider before giving probiotics to preterm infants and to report any adverse events to the FDA's MedWatch Adverse Event Reporting program.